Phase II trial of erlotinib and bevacizumab in patients with advanced upper gastrointestinal cancers
2011 ◽
Vol 51
(2)
◽
pp. 234-242
◽
Kristoffer S. Rohrberg
◽
René K. Olesen
◽
Per Pfeiffer
◽
Morten Ladekarl
◽
Helle Pappot
◽
...
2009 ◽
Vol 7
(2)
◽
pp. 363
K. Rohrberg
◽
H. Pappot
◽
B.G. Skov
◽
G. Høyer-Hansen
◽
I.J. Christensen
◽
...
1995 ◽
Vol 121
(2)
◽
pp. 103-106
◽
Merry Tetef
◽
Kim Margolin
◽
Chul Ahn
◽
Steven Akman
◽
Warren Chow
◽
...
2014 ◽
Vol 25
◽
pp. iv521
K. Ishido
◽
K. Higuchi
◽
M. Azuma
◽
T. Sasaki
◽
S. Tanabe
◽
...
2009 ◽
Vol 7
(4)
◽
pp. 28
K.S. Rohrberg
◽
I. Buysschaert
◽
H. Pappot
◽
B. Guldhammer Skov
◽
I.J. Christensen
◽
...
1995 ◽
Vol 13
(3)
◽
pp. 223-227
◽
Avi I. Einzig
◽
Stuart Lipsitz
◽
Peter H. Wiernik
◽
Al. B. Benson
2004 ◽
Vol 4
(1)
◽
pp. 46-50
◽
Karin Jordan
◽
Olaf Kellner
◽
Thomas Kegel
◽
Hans-Joachim Schmoll
◽
Axel Grothey
Shao-Hui Chen
◽
Tang-Mi Yuan
◽
Jiao Zhang
◽
Hua Bai
◽
Ming Tian
◽
...
1996 ◽
Vol 13
(2)
◽
pp. 87-93
◽
Avi I. Einzig
◽
DOnna Neuberg
◽
Scot C. Remick
◽
Daniel D. Karp
◽
Peter J. O’Dwyer
◽
...
2007 ◽
Vol 177
(4S)
◽
pp. 461-461
◽
Christopher G. Wood
◽
David Chang
◽
Run Wang
◽
Yu Shen
◽
Curtis A. Pettaway
◽
...
2005 ◽
Vol 173
(4S)
◽
pp. 360-360
Peter E. Clark
◽
Diana Stindt
◽
M. Craig Hall
◽
Michele Harmon
◽
James F. Lovato
◽
...